Watson introduces herpes drug Famciclovir
Famciclovir, an antiviral, is indicated for the treatment for immunocompetent adult patients with herpes labialis (cold sores), genital herpes and for HIV infected adult patients for treatment of
China-based IMPACT Therapeutics and Pharmanovia have entered an exclusive licensing deal worth up to €423.5m ($488.3m), giving Pharmanovia rights to manufacture, develop, and commercialise senaparib in 66 countries.